Publication | Closed Access

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaPathologyMolecular DiagnosticsAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyCancer ResearchMinimal Residual DiseaseHealth Sciences